The study, published in JAMA, found these adverse gastrointestinal effects happen in non-diabetic patients using the drugs specifically for weight loss.
It’s a retroactive study comparing it to data from people taking bupropion-naltrexone.
People taking Semaglutide were five times more likely to drink alcohol, a common cause of pancreatitis, probably because naltrexone is used to treat alcoholism.
It’s a retroactive study comparing it to data from people taking bupropion-naltrexone.
People taking Semaglutide were five times more likely to drink alcohol, a common cause of pancreatitis, probably because naltrexone is used to treat alcoholism.
But they also found an elevated rate of gastroparesis, which isn’t associated with alcoholism like pancreatitis
The incidence rate was rare, either way